Page last updated: 2024-09-03

gyki 53655 and ibotenic acid

gyki 53655 has been researched along with ibotenic acid in 1 studies

Compound Research Comparison

Studies (gyki 53655)	Trials (gyki 53655)	Recent Studies (post-2010) (gyki 53655)	Studies (ibotenic acid)	Trials (ibotenic acid)	Recent Studies (post-2010) (ibotenic acid)
111	0	22	2,108	1	211

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lodge, D; Palmer, AJ	1

Other Studies

1 other study(ies) available for gyki 53655 and ibotenic acid

Article	Year
Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655. European journal of pharmacology, 1993, Jan-15, Volume: 244, Issue:2 Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzodiazepines; Benzothiadiazines; Cerebral Cortex; Diuretics; Excitatory Amino Acid Antagonists; Ibotenic Acid; In Vitro Techniques; Kainic Acid; N-Methylaspartate; Quinoxalines; Rats; Receptors, AMPA; Sodium Chloride Symporter Inhibitors	1993

Article

Year

Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655.

European journal of pharmacology, 1993, Jan-15, Volume: 244, Issue:2

Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzodiazepines; Benzothiadiazines; Cerebral Cortex; Diuretics; Excitatory Amino Acid Antagonists; Ibotenic Acid; In Vitro Techniques; Kainic Acid; N-Methylaspartate; Quinoxalines; Rats; Receptors, AMPA; Sodium Chloride Symporter Inhibitors

1993